In response to: Multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Pub Date : 2021-04-01 Epub Date: 2021-01-27 DOI:10.1016/j.ijid.2021.01.049

Luis Peñarrubia, Maria Ruiz, Roberto Porco, Sonia N Rao, Stephen A Vella, Martí Juanola-Falgarona, Davide Manissero, Marta López-Fontanals, Josep Pareja

引用次数: 4

查看原文本刊更多论文

针对以下问题:在COVID-19疫情期间，严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)实时RT-PCR检测组中的多项检测可降低新基因组变异导致敏感性丧失的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

自引率

0.00%

发文量